Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
04/2014
04/16/2014CN103724327A High-efficiency and green method for preparing pymetrozine
04/16/2014CN103724326A High-purity fasudil hydrochloride preparation method
04/16/2014CN103724325A Method for preparing sulfinyl-1-hydrogen-benzimidazole derivative
04/16/2014CN103724324A Imidacloprid-like ramification and preparing method thereof
04/16/2014CN103724323A Preparation method of pomalidomide
04/16/2014CN103724322A Androgen receptor modulators and uses thereof
04/16/2014CN103724271A Substituted imidazole-1-ethylene compound and application thereof
04/16/2014CN103724255A Preparation method of compounds used for detecting explosive RDX (Research Department eXplosive) and based on acylamino dihydropyridine structure
04/16/2014CN103724251A STAT3 (Signal Transducer and Activator of Transcription 3)-targeting small molecular compound as well as preparation method and application thereof
04/16/2014CN103012843B Benzotriazole-hindered amine composite photostabilizer and preparation method thereof
04/16/2014CN102942558B Preparation method of benzazepine derivatives
04/16/2014CN102633778B Synthesis method of anti-AIDS medicine delavirdine
04/16/2014CN102633777B Dabigatran etexilate 2-ketoglutarate as well as preparation method and application thereof
04/16/2014CN102633709B Main luminophor material and organic light emitting diode containing same
04/16/2014CN102617553B Agricultural ryanodine receptor activator and preparation method and application thereof
04/16/2014CN102603716B Method for preparing (S)-pantoprazole in high-enantioselectivity way
04/16/2014CN102574836B Aminopyrazole derivative
04/16/2014CN102574835B Compounds useful for treating cancer
04/16/2014CN102558145B Method for preparing balofloxacin
04/16/2014CN102382100B Preparation method of imatinib
04/16/2014CN102369195B Autotaxin inhibitors
04/16/2014CN102264725B 蛋白激酶抑制剂 Protein kinase inhibitors
04/16/2014CN102164900B 3-amino-indazole or 3-amino-4,5,6,7-tetrahydro-indazole derivatives
04/16/2014CN102066366B Novel substituted pyridin-2-ones and pyridazin-3-ones
04/16/2014CN101970425B Crystalline forms and two solvated forms of 4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2(1h)-one lactic acid salts
04/16/2014CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof
04/16/2014CN101578261B Heteroaryl-substituted serine amides
04/15/2014US8697888 Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
04/15/2014US8697880 Compounds useful for the synthesis of S- and R-omeprazole and a process for their preparation
04/15/2014US8697879 Chiral synthesis of pyrrolidine core compounds en route to neuronal nitric oxide synthase inhibitors
04/15/2014US8697877 Oxyindole derivatives with motilin receptor agonistic activity
04/15/2014US8697876 Compositions and methods of synthesis of pyridinolypiperidine 5-HT1F agonists
04/15/2014US8697873 Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
04/15/2014US8697870 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
04/15/2014US8697866 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds
04/15/2014US8697865 Cyclic amide derivative, and its production and use
04/15/2014US8697737 Raf modulators and methods of use
04/15/2014US8697734 Method for controlling particular insect pests by applying anthranilamide compounds
04/15/2014US8697731 Derivatives of 2-pyridin-2-yl-pyrazol-3(2H)-one, preparation and therapeutic use thereof
04/15/2014US8697730 5-lipoxygenase activating protein (FLAP) inhibitor
04/15/2014US8697721 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
04/15/2014US8697717 Inhibitors of histone deacetylase
04/15/2014US8697714 Quinazolinone based fluorogenic probes
04/15/2014US8697698 Pyrazole compounds useful as protein kinase inhibitors
04/15/2014US8697690 Isoindolone M1 receptor positive allosteric modulators
04/15/2014US8697685 Chemical compounds
04/15/2014US8697673 Bicyclic pyridinones
04/15/2014US8697604 Labeling agents for mass spectrometry comprising tertiary amines
04/15/2014CA2786089C Nitrogen-containing heterocyclic compound and agricultural fungicide
04/15/2014CA2660376C Salts of benzimidazolyl pyridyl ethers and formulations thereof
04/15/2014CA2631832C Improved process for the preparation of 4-(benzimidazolylmethylamino)-benzamides and the salts thereof
04/10/2014WO2014055955A1 Gdf-8 inhibitors
04/10/2014WO2014055938A1 Novel compounds, their preparation and their uses
04/10/2014WO2014055647A1 (sulfinyl and sulfonyl benzimidazolyl) pyrimidines and triazines, pharmaceutical compositions thereof, and their use for treating proliferative diseases
04/10/2014WO2014055603A1 Process for the preparation of an hiv integrase inhibitor
04/10/2014WO2014055548A1 Anti-fibrotic pyridinones
04/10/2014WO2014055286A1 Methods for improving chicken production
04/10/2014WO2014054635A1 Imidazole derivative
04/10/2014WO2014054634A1 Pyrimidine derivative
04/10/2014WO2014054596A1 Organic electroluminescent element, organic el lighting and organic el display device
04/10/2014WO2014053665A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses
04/10/2014WO2014053516A1 1,2,4-triazine derivatives for the treatment of viral infections.
04/10/2014WO2014053491A1 Inhibitors of histone demethylases
04/10/2014WO2014053407A1 N-thio-anthranilamide compounds and their use as pesticides
04/10/2014WO2014053210A1 Pyrrolidines
04/10/2014WO2014026657A3 A process for the preparation of a derivative of 2-methyl-2'-phenylpropionic acid using new intermediates
04/10/2014WO2014023390A3 (aza-)isoquinolinone derivatives
04/10/2014US20140100370 Method and apparatus for producing oxidized compound
04/10/2014US20140100239 Quinazolinedione derivatives as parp inhibitors
04/10/2014US20140100234 Quinoline derivatives as pi3 kinase inhibitors
04/10/2014US20140100225 Novel compounds, their preparation and their uses
04/10/2014US20140100215 Methods of Using PI3K and MEK Modulators
04/10/2014US20140100214 Heterocyclic compounds and uses thereof
04/10/2014US20140100213 Triazolones as fatty acid synthase inhibitors
04/10/2014US20140100212 Compounds as tyrosine kinase modulators
04/10/2014US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof
04/10/2014US20140100210 Guanidine compound
04/10/2014US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
04/09/2014EP2716684A1 Compounds, pharmaceutical compositions and a method for the prophylaxis and treatment of the adhesion process
04/09/2014EP2714685A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714684A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014EP2714678A1 Imidazole derivatives
04/09/2014EP2714677A1 Pyridine-and pyrazine derivatives
04/09/2014EP2714676A1 A process for the preparation of polymorphic form i of etoricoxib
04/09/2014EP2714665A1 New 1-arylpiperazinic ligands of 5-ht7 receptor and use thereof
04/09/2014EP2714662A1 Neprilysin inhibitors
04/09/2014EP2714660A1 Neprilysin inhibitors
04/09/2014EP2714658A1 Novel hybrid cholinesterase inhibitors
04/09/2014EP2714654A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group
04/09/2014CN103717603A Novel compounds for organic electronic material and organic electroluminescent device using the same
04/09/2014CN103717602A Kinase inhibitors
04/09/2014CN103717595A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
04/09/2014CN103717588A Novel pyrazole derivative
04/09/2014CN103717581A N-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
04/09/2014CN103717574A Novel compounds and compositions for the inhibition of nampt
04/09/2014CN103710021A Fluorescent dye with nitrobenzimidazole as RNA (ribonucleic acid) recognition group as well as preparation method and application of fluorescent dye
04/09/2014CN103709196A Complex containing 2-aminopyridine tetradentate ligand and application thereof
04/09/2014CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs
04/09/2014CN103709148A Novel substituted pyridine-2-ones and pyidazin-3-ones
04/09/2014CN103709147A Flumatinib mesylate crystal form, preparation method thereof and applications thereof
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 1080